Z-2592-2017 Class II Terminated

Recalled by Ion Beam Applications S.A. — Louvain La Neuve

FDA device recall Z-2592-2017 was initiated by Ion Beam Applications S.A. on Feb 9, 2017 and is designated Class II. Reason for recall: It has been observed during testing that there could be clinically non-negligible amount of dark current (a well-known physics effect observed in cyclotron) in Pencil Beam Scanning (PBS) treatment… The recall status is terminated (terminated Jul 14, 2023). Affected quantity: 18 systems ( 10 in the US).

Recall details

Product Type
Devices
Report Date
Jun 28, 2017
Initiation Date
Feb 9, 2017
Termination Date
Jul 14, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18 systems ( 10 in the US)

Product description

Proteus 235

Reason for recall

It has been observed during testing that there could be clinically non-negligible amount of dark current (a well-known physics effect observed in cyclotron) in Pencil Beam Scanning (PBS) treatment mode when system is not irradiating between layers.

Distribution pattern

Worldwide Distribution - US Distribution to the states of : MA, FL, VA, PA, IL, NJ, WA, TN, LA and TX., and to the countries of: Germany, South Korea, France, Czech Republic, Italy, Poland and Sweden.

Code information

Serial Numbers: PAT.000,PAT.003, PAT.006, PAT.107, PAT.108, PAT.109, PAT.111, PAT.112, PAT.113, PAT.114, SAT.115, SAT.116, SAT.117, SAT.119, SAT.120, SAT.122, SAT.123, SAT.126

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2592-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2592-2017. Report a data issue: hello@regdatalab.com.